Medtronic's stock has climbed steadily, posting a 14.6% return over the past year. As shares hover around $102, investors are asking if the rally has left the stock overvalued or if there's still room to grow. A deep dive into key valuation metrics reveals a nuanced picture.
Medtronic moves to acquire AI-powered coronary analysis firm CathWorks while securing key U.S. coverage for its latest automated insulin delivery system, signaling a dual-front advance in cardiovascular and diabetes care.
U.S. corn futures posted modest gains in midday trading Wednesday, supported by fresh export sales data and anticipation of upcoming USDA reports. The market's resilience comes amid mixed signals from the ethanol sector.
Soybean prices rallied sharply at midday following a reported phone call between former President Trump and China's President Xi, with discussions centering on a potential increase in Chinese purchase commitments.
Soybean futures edged lower Wednesday morning, giving back a portion of the previous session's gains. The market is weighing new U.S. Treasury guidance on biofuel tax credits against a backdrop of softer EU import demand.
U.S. corn prices edged lower in Wednesday's pre-market session, giving back a portion of the previous day's gains. Traders are weighing fresh Treasury guidance on biofuel tax credits against expectations for softer ethanol output and ongoing global demand.
Medtronic has exercised its option to acquire CathWorks, the developer of the AI-powered FFRangio System, in a deal valued at $585 million. The acquisition, pending regulatory approval, aims to accelerate the transformation of coronary artery disease diagnosis and solidify Medtronic's position in the digital cath lab.
In a sector often prioritizing R&D over shareholder returns, healthcare giants AbbVie and Medtronic stand out with their long histories of dividend growth and robust cash flows, offering investors a rare blend of stability and income.
U.S. soybean futures advanced Tuesday, buoyed by a rally in bean oil markets following new federal tax credit guidance. The gains come despite a mixed domestic crush report and softer European import figures, highlighting the complex dynamics in global oilseed markets.
Corn futures posted modest gains at midday Tuesday, buoyed by a record-setting monthly ethanol usage report and fresh international demand. The market continues to find support from robust consumption data.
Medtronic moves to acquire CathWorks and its non-invasive artery diagnostic system in a deal worth up to $585 million, aiming to strengthen its dominant cardiac portfolio and address a leading cause of heart disease.
U.S. corn futures edged lower at Monday's midday, pressured by a stronger dollar, falling crude oil, and a weekly export inspections report that fell short of last year's pace. The market also digested trade developments with India and positioning data from speculators.
Soybean futures traded lower midday Monday, pressured by mixed export figures and a growing Brazilian harvest. The market also digested news of a potential U.S.-India trade deal that could impact agricultural flows.
While Medtronic's shares have trailed the S&P 500 over the past year, Wall Street maintains a cautiously optimistic stance, buoyed by strong recent earnings and raised guidance.
Shares of insulin pump maker Tandem Diabetes Care have plummeted over 80% in five years, trading near $20. A deep dive into valuation metrics suggests the stock may now be modestly undervalued, but significant risks and competitive pressures remain.
Medtronic's expanded partnership with Mindray integrates its monitoring technologies into ASC-focused platforms, a strategic move to embed itself in a high-growth segment while analysts debate its impact on the broader investment thesis.
The global investment manager reported robust growth in money market and equity strategies during its Q4 2025 earnings call, while detailing expansion into digital assets and the pending acquisition of real estate specialist FCP.
While fully autonomous robotic surgeons remain on the horizon, the foundational technology and data ecosystems being built today are setting the stage for a transformative shift. Two industry giants, Intuitive Surgical and Medtronic, offer investors distinct pathways to capitalize on this evolving landscape.
Corn futures extended losses on Friday, pressured by a strengthening U.S. dollar and weaker crude oil prices. Despite robust export sales data running ahead of historical pace, front-month contracts fell 5 to 5.5 cents, pushing the national average cash price lower.
A recent physician survey on renal denervation procedure volumes has prompted analysts to adopt a more measured view of Medtronic's near-term growth potential, even as the medical device giant remains a favored long-term holding.
